CRISPR Biotech Engineering is an early-stage genome editing company that is committed to using innovative CRISPR-Cas9 technology to improve human lives.

CRISPR Biotech Engineering

Eligo Bioscience is a biotechnology company focused on the development of innovative microbiome therapies. The company leverages cutting-edge technology to engineer beneficial microbes that can specifically target and eliminate harmful bacteria, aiming to treat a range of diseases linked to the human microbiome.

David Bikard

Timothy K. Lu

Xavier Duportet

Luciano Marraffini

Eligo Bioscience

Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. With a distinguished team including co-founder and CRISPR-Cas genome editing co-inventor Jennifer Doudna, Mammoth is addressing challenges across healthcare, agriculture, environmental monitoring, biodefense, and more.

Janice Chen

Trevor Martin

Jennifer Doudna

Ashley Tehranchi

Lucas Harrington

Mammoth Biosciences

Sherlock Biosciences engineers biology to deliver products for molecular diagnostics, aiming to democratize and decentralize testing to personalize healthcare and impact global health.

Sherlock Biosciences

CRISPR Biotech Engineering is an early-stage genome editing company that focuses on using CRISPR-Cas9 technology to improve human life. The company aims to empower scientists and researchers with knowledge around CRISPR.

Metric
Company Name	CRISPR Biotech Engineering	Eligo Bioscience	Mammoth Biosciences	Sherlock Biosciences
Symbol
MSH ID	COM:CRISPR-BTE	BIO:ELIGO	BIO:MAMMOTH	BIO:SHERLOCK
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Biotechnology	Biotechnology	Biotechnology
Country	GB	FR	US	US
Stage			Series D
Employee Count		42	185	75
Website	crispr-bte.com	eligo.bio	mammoth.bio	sherlock.bio
LinkedIn		eligo-bioscience	mammothbio	sherlock-biosciences
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			6.85K
Web Traffic Growth			-0.30
Valuation
Raised Capital			150M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CRIS

COM:CRISPR-BTE

CRISPR Biotech Engineering

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue